Electrical Stimulation for the Treatment of Glaucoma (rtACS)
Evaluate the Safety and Efficacy of Repetitive, Transorbital Alternating Current Stimulation (rtACS) for the Treatment of Glaucoma
Sponsor: NYU Langone Health
This observational or N/A phase trial investigates Glaucoma and Glaucoma, Open-Angle and is currently ongoing. NYU Langone Health leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Apr 28, 2026 — Present [daily]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting · Phase: NA → None
-
Jan 2025 — Apr 2026 [monthly]
Recruiting NA
-
Sep 2024 — Jan 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Mar 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Apr 2023 — Mar 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Dec 2022 — Apr 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your eye pressure.
Contact Information
- NYU Langone Health
- Otto-von-Guericke University Magdeburg
- Stanford University
- Wills Eye
For direct contact, visit the study record on ClinicalTrials.gov .